Overview
Description
Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.
Healthcare Biopharmaceuticals Other Biopharmaceuticals United States
Financials
Key metrics
| Market capitalisation, EUR | 9,372 m |
| EPS, EUR | -3.78 |
| P/B ratio | 5.6 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 10 m |
| Net income, EUR | -298 m |
| Profit margin | -2,957.71% |
What ETF is Avidity Biosciences in?
There are 4 ETFs which contain Avidity Biosciences. All of these ETFs are listed in the table below. The ETF with the largest weighting of Avidity Biosciences is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.72% | Equity United States Health Care Biotech | 45 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.01% | Equity World Social/Environmental | 497 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Distributing | 0.01% | Equity North America Social/Environmental | 27 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0.13% | Equity United States Small Cap | 185 |
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
